Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathways Software to Invitrogen

NEW YORK, June 1 (GenomeWeb News) - GeneGo has licensed its pathways database and software system to Invitrogen, the companies said today.

 

The multi-year licensing agreement includes plans for a collaboration to develop new capabilities for the software. The companies did not disclose the financial details of the agreement.

 

Michael Stapleton, general manager and vice president of Invitrogen's bioinformatics business, said in a statement that the licensing deal would "help us in making bioinformatics an intrinsic part of Invitrogen's solutions set for life science research."

 

GeneGo, of St. Joseph, Mich., has developed a program, MetaCore, that includes a database of molecular cellular pathways and is designed to integrate data from different levels of cellular function, including membrane receptors, signal transduction, transcription factors, and effector networks. The target users are pharmaceutical scientists engaged in target selection and validation, biomarker identification, and toxicology, the company said.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.